Fundz

Imbed Biosciences, Inc reported raising $1.06 Million in an initial SEC Form D filing, from an offering of $3.5 Million

PRIVATEOct 29, 2018$1.1M of $3.5M raised

Amount Raised

$1.06 Million

$1.06 Million sold, per SEC Form D (first sale Oct 29, 2018)

Round Type

Seed

MadisonBiotechnologyMedical Device

Who else raised in Medical Device and Biotechnology around the same time

Companies in the same sectors as Imbed Biosciences Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Conformal Medical raised $8.2M on December 6, 2018.
  • Lifecore Biomedical raised $19M on December 6, 2018.
  • Otolith Labs raised $750K (Seed) on November 28, 2018.
  • Atia Vision, Inc. raised $3.3M (Seed) on November 21, 2018.
  • Neochord raised $21M on November 13, 2018.
  • Eximis Surgical raised $7.5M on November 8, 2018.

Who to call at Imbed Biosciences Inc., and when

A new round usually means Imbed Biosciences Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Imbed Biosciences Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Imbed Biosciences Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Imbed Biosciences Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Imbed Biosciences Inc.

Location

5520 Nobel Drive

Madison, Wisconsin, United States

About

Imbed Biosciences Inc. is a privately held medical device company emerging as a leader in the development of advanced synthetic therapies for the treatment of surgical wounds, burns, chronic ulcers, and soft-tissue repair. Imbed has a portfolio of products commercially available, and in development, based on its patented Microlyte® technology. Imbed Biosciences is registered with U.S. FDA as a medical device manufacturer and maintains an ISO 13485 certified Quality Management System.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Imbed Biosciences Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMichael S., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Imbed Biosciences Inc.'s next move

See what Strategic adds

Imbed Biosciences Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.